Please assess the completion status of the following clinical trial:

Trial Title: Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* healthy volunteers, either with PCOS/PCOS-like ovaries, or with normal ovaries, who undergo oocyte donation for research~* AFC at least 10~* AMH: \> 5 μg/L~* Female age \< 36 years~Exclusion Criteria:~* major uterine or ovarian abnormalities

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- in-vitro maturation of oocytes (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).